Is Adagio Medical Holdings, Inc Common Stock (ADGM) overvalued? · rev $269.0K
Adagio Medical Holdings, Inc Common Stock (ADGM) is a medical devices company listed on NASDAQ.
This page asks whether Adagio Medical Holdings, Inc Common Stock (ADGM) looks expensive on cached numbers — not a short thesis.
Latest reported ADGM revenue for 2024-12-31 was $269.0K. Net income was -$53.8M. Revenue was down 19.2% from 2024-07-30 to 2024-12-31. ADGM currently screens at market cap $15.5M.
ADGM currently screens at market cap $15.5M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next ADGM 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the ADGM stock page for the full model, not this heading.
Not investment advice.